The role of PET/CT for nodal staging in primary stage II/III breast cancer patients
作者： Suzana C Teixeira , Marie-Jeanne TFD Vrancken Peeters , Marcel PM Stokkel , Emiel JTH Rutgers , Renato A Valdés Olmos
DOI: 10.2217/BMT.15.9
关键词:
摘要: SUMMARY Modalities that are conventionally used for regional and distant metastases staging, in clinical stage II/III breast cancer patients (ultrasonography, computed tomography [CT], MRI bone scan), may underestimate the spread of disease. The 18-fluoro-deoxy-glucose whole body PET with CT (18F-FDG PET/CT) is able to more accurately visualize number axillary lymph node metastases, internal mammary chain, periclavicular disease than previously mentioned modalities. Therefore, PET/CT scanning results a individualized therapy plan. Additionally, 18F-FDG seems useful monitor response pre-operative systemic treatment primary tumor ER+ triple-negative subtypes.
futuremedicine.com 
sci-hub.se 参考文章(81)
Pieter J Tanis, Omgo E Nieweg, Renato A Valdés Olmos, Emiel J Th Rutgers, Bin BR Kroon, History of sentinel node and validation of the technique. Breast Cancer Research. ,vol. 3, pp. 109- 112 ,(2001) , 10.1186/BCR281
Srinivasamurthy Devaraj, Mohd Iqbal, Jill Donnelly, Allan P Corder, None, Axillary ultrasound in invasive breast cancer: experience of our surgeons. Breast Journal. ,vol. 17, pp. 191- 195 ,(2011) , 10.1111/J.1524-4741.2010.01043.X
B. E. Schaafsma, F. P. R. Verbeek, D. D. D. Rietbergen, B. van der Hiel, J. R. van der Vorst, G. J. Liefers, J. V. Frangioni, C. J. H. van de Velde, F. W. B. van Leeuwen, A. L. Vahrmeijer, Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. British Journal of Surgery. ,vol. 100, pp. 1037- 1044 ,(2013) , 10.1002/BJS.9159
Michael T. Milano, Kenneth Y. Usuki, Deepinder Singh, Neil Joyce, Yuhchyau Chen, Mary Z. Hare, Michael C. Schell, Thomas Lundquist, Hong Zhang, Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung. Journal of Thoracic Disease. ,vol. 6, pp. 369- 374 ,(2014) , 10.3978/J.ISSN.2072-1439.2013.12.03
Isabelle Segaert, Felix Mottaghy, Sarah Ceyssens, Walter De Wever, Sigrid Stroobants, Chantal Van Ongeval, Eric Van Limbergen, Hans Wildiers, Robert Paridaens, Ignace Vergote, Marie-Rose Christiaens, Patrick Neven, Additional Value of PET–CT in Staging of Clinical Stage IIB and III Breast Cancer Breast Journal. ,vol. 16, pp. 617- 624 ,(2010) , 10.1111/J.1524-4741.2010.00987.X
Rasha Wessam, Rasha Mohamed Kamal, Lamiaa Adel Salah, Dorria Saleh Salem, Sahar Mahmoud Mansour, Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up Journal of Thoracic Disease. ,vol. 5, ,(2013) , 10.3978/J.ISSN.2072-1439.2013.05.02
N. Avril, C.A. Rosé, M. Schelling, J. Dose, W. Kuhn, S. Bense, W. Weber, S. Ziegler, H. Graeff, M. Schwaiger, Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations Journal of Clinical Oncology. ,vol. 18, pp. 3495- 3502 ,(2000) , 10.1200/JCO.2000.18.20.3495
Emiel J. Rutgers, Mila Donker, Marieke Evelien Straver, Philip Meijnen, Cornelis J. H. Van De Velde, Robert E. Mansel, Helen Westenberg, Lorenzo Orzalesi, Willem H. Bouma, Huub van der Mijle, Grard A. P. Nieuwenhuijzen, Sanne C. Veltkamp, Leen Slaets, Carlo G. M. Messina, Nicole J. Duez, Coen Hurkmans, Jan Bogaerts, Geertjan van Tienhoven, Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023). Journal of Clinical Oncology. ,vol. 31, ,(2013) , 10.1200/JCO.2013.31.15_SUPPL.LBA1001
OTTO WARBURN, FRANK DICKENS, THE METABOLISM OF TUMORS The American Journal of the Medical Sciences. ,vol. 182, pp. 123- ,(1931) , 10.1097/00000441-193107000-00022
Young Jin Choi, Young Duck Shin, Yoon Hee Kang, Moon Soo Lee, Min Koo Lee, Byung Sun Cho, Yoon Jung Kang, Ju Seung Park, The Effects of Preoperative 18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study Journal of Breast Cancer. ,vol. 15, pp. 441- 448 ,(2012) , 10.4048/JBC.2012.15.4.441